| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2140770 | Lung Cancer | 2014 | 7 Pages |
Abstract
The drop of Treg levels during neoadjuvant chemo-immunotherapy in NSCLC patients significantly correlates with clinical response. However, Treg at diagnosis are not linked to inferior clinical response to chemo-immunotherapy in NSCLC in vivo even though Treg efficiently inhibit ADCC in vitro.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andreas Pircher, Gabriele Gamerith, Arno Amann, Susanne Reinold, Helmut Popper, Anneliese Gächter, Georg Pall, Ewald Wöll, Herbert Jamnig, Günther Gastl, Anna Maria Wolf, Wolfgang Hilbe, Dominik Wolf,